ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,928Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 11

$317K Total Retail Price of All Prescriptions

Rank: 6 out of 11

291 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

25% of this provider’s 291 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

1% of this provider’s 12,449 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$25 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

44 is the average number of prescriptions (including refills) per patient, compared to an average of 34.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
FUROSEMIDE 855 855 1 2
POTASSIUM CHLORIDE 580 564 2 8
SIMVASTATIN 532 503 3 6
LEVOTHYROXINE SODIUM 507 500 4 1
HYDROCODONE-ACETAMINOPHEN 439 427 S3 5 5
OMEPRAZOLE 437 423 6 12
ENALAPRIL MALEATE 428 417 7 45
WARFARIN SODIUM 426 413 8 3
METOPROLOL TARTRATE 370 361 9 10
AMLODIPINE BESYLATE 369 348 10 7
RANITIDINE HCL 362 357 11 29
CITALOPRAM HBR 319 308 12 11
ATENOLOL 301 287 13 33
LOSARTAN POTASSIUM 269 261 14 25
GABAPENTIN 250 250 15 9
SPIRONOLACTONE 247 245 16 34
ALLOPURINOL 237 226 17 32
DOXAZOSIN MESYLATE 202 193 18 67
POLYETHYLENE GLYCOL 3350 194 190 19 41
LOVASTATIN 180 180 20 48
DIGOXIN 179 179 21 28
ALENDRONATE SODIUM 178 178 22 47
LISINOPRIL 119 89 23 4
CARVEDILOL 112 112 24 15
FINASTERIDE 110 99 25 69
NIFEDIPINE ER 107 107 26 133
GLIMEPIRIDE 106 105 27 59
CEPHALEXIN 101 89 28 82
DILTIAZEM ER 99 99 29 89
MIRTAZAPINE 91 66 30 17
NITROGLYCERIN PATCH 85 85 31 144
METFORMIN HCL 82 78 32 16
DONEPEZIL HCL 81 81 33 14
TAMSULOSIN HCL 79 79 34 18
DOXYCYCLINE HYCLATE 77 70 35 64
HYDROCHLOROTHIAZIDE 75 71 36 21
BENAZEPRIL HCL 73 73 37 118
PRAVASTATIN SODIUM 71 71 38 72
CARBIDOPA-LEVODOPA 71 71 38 35
ZOLPIDEM TARTRATE 67 67 40 65
PREDNISONE 67 66 40 36
TRAMADOL HCL 67 67 40 31
LANTUS 66 65 43 20
CLOPIDOGREL 65 65 44 40
INSULIN SYRINGE 63 54 45 158
CALCITONIN-SALMON 63 54 45 158
SULFAMETHOXAZOLE-TRIMETHOPRIM 62 57 47 70
NAMENDA 61 61 48 13
FLUTICASONE PROPIONATE 60 58 49 55
PROAIR HFA 56 54 50 119
VERAPAMIL ER 54 52 51 125
TRIAMCINOLONE ACETONIDE 52 50 52 75
HUMALOG 51 50 53 93
FAMOTIDINE 50 50 54 72
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 26, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.